Status:
COMPLETED
MRI Exploration of Meningeal Inflammatory Disease
Lead Sponsor:
Fondation Ophtalmologique Adolphe de Rothschild
Conditions:
MRI
Eligibility:
All Genders
18+ years
Brief Summary
Patients who have agreed to participate in the study will complete the MRI protocol as part of routine care, to which two additional sequences of 6 minutes duration will be added. The MRI of routine ...
Eligibility Criteria
Inclusion
- Patient over 18 years old
- To benefit as part of his treatment of an MRI with injection of gadolinium
- Express consent to participate in the study
- Affiliate or beneficiary of a social security scheme
- For the ancillary study to meet secondary endpoint number 5:
- Patient over 18 years old
- To benefit as part of his treatment of an MRI with injection of gadolinium
- Hospitalized for an expected period of at least 48 hours after the time of inclusion
- Express consent to participate in the study
- Affiliate or beneficiary of a social security scheme
Exclusion
- Patient benefiting from a legal protection measure
- Pregnant or breastfeeding woman
Key Trial Info
Start Date :
June 16 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 16 2023
Estimated Enrollment :
302 Patients enrolled
Trial Details
Trial ID
NCT04707170
Start Date
June 16 2021
End Date
June 16 2023
Last Update
December 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hhopital fondation adolphe de rothschild
Paris, France, 75019